ArticleCancers2026

Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma.

Simona Andrea Ruckstuhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.